COLL vs CTVA · P/E 17, rev $181.9M vs P/E 42, rev $16.91B
Collegium Pharmaceutical Inc (COLL) versus Corteva Inc (CTVA) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Corteva Inc (CTVA) is a agricultural inputs company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported CTVA revenue for 2024-12-31 was $16.91B. Net income was $919.0M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
Not investment advice. Open the COLL and CTVA stock pages for the full models.
Not investment advice.